Kilpest India Ltd
BSE:532067
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Kilpest India Ltd
Cash Equivalents
Kilpest India Ltd
Cash Equivalents Peer Comparison
UPL
FACT
BAYERCROP
PIIND
COROMANDEL
Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
| Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
K
|
Kilpest India Ltd
BSE:532067
|
Cash Equivalents
₹104.6m
|
CAGR 3-Years
-49%
|
CAGR 5-Years
43%
|
CAGR 10-Years
N/A
|
|
|
UPL Ltd
NSE:UPL
|
Cash Equivalents
₹60.4B
|
CAGR 3-Years
8%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
|
Fertilisers And Chemicals Travancore Ltd
NSE:FACT
|
Cash Equivalents
₹493.3m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
57%
|
CAGR 10-Years
N/A
|
|
|
Bayer Cropscience Ltd
NSE:BAYERCROP
|
Cash Equivalents
₹5.8B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
121%
|
CAGR 10-Years
N/A
|
|
|
PI Industries Ltd
NSE:PIIND
|
Cash Equivalents
₹18.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Coromandel International Ltd
NSE:COROMANDEL
|
Cash Equivalents
₹28.6B
|
CAGR 3-Years
58%
|
CAGR 5-Years
78%
|
CAGR 10-Years
20%
|
See Also
What is Kilpest India Ltd's Cash Equivalents?
Cash Equivalents
104.6m
INR
Based on the financial report for Dec 31, 2023, Kilpest India Ltd's Cash Equivalents amounts to 104.6m INR.
What is Kilpest India Ltd's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
43%
Over the last year, the Cash Equivalents growth was -6%. The average annual Cash Equivalents growth rates for Kilpest India Ltd have been -49% over the past three years , 43% over the past five years .
You don't have any saved screeners yet
